Action Changement Date
Amgen USD 6.39B 169M 2026-09
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.93B 362M 2026-06
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Heron Therapeutics USD 54.57M 2.33M 2022-12
Incyte USD 134.25M 21.71M 2026-09
Intrexon USD 287K 68K 2022-12
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 14.51M 4.24M 2026-09
MacroGenics USD 9.5M 1.59M 2026-03
MannKind USD 48.47M 4.05M 2026-09
Merck USD 6.16B 43M 2026-09
Novartis USD 6.1B 116M 2026-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Thermo Fisher Scientific USD 5.64B 16M 2026-09
Veracyte USD 25.82M 3.16M 2026-09